论文部分内容阅读
目的:观察格拉诺赛特防治EAP 方案化疗引起白细胞下降的作用。方法:44 例胃癌患者接受EAP 方案化疗, 并给予格拉诺赛特(G- CSF) 100μg/ 日。结果: 格拉诺赛特组的Ⅲ度及Ⅳ度白细胞减少明显少于对照组。结论:格拉诺赛特可改善EAP 方案化疗引起的白细胞减少,副作用低。
OBJECTIVE: To observe the effect of Granasterate in the prevention of leukopenia caused by chemotherapy for EAP. METHODS: Forty-four patients with gastric cancer underwent EAP regimen and given Granocose (G-CSF) 100 μg/day. Results: The grade III and IV leucopenia in the Granosite group was significantly less than in the control group. Conclusion: Granoside can improve leukopenia induced by EAP regimen chemotherapy with low side effects.